subsidiary: search

Silverstar Holdings Ltd's subsidiary launches 'Jagged Alliance' for Nintendo DS

Empire Interactive, a subsidiary of Silverstar Holdings (NasdaqCM:SSTR), a publisher of entertainment software, announced yesterday (26 August) the introduction of Jagged Alliance for the Nintendo DS platform. The Nintendo DS platform title of this PC game is being developed by another Silverstar subsidiary, Strategy First Inc and Cypron Studio. The official release is planned for the first half of 2009. Jagged Alliance is a fusion of a role-playing game mixed with turn-based tactical combat. Empire Interactive has made a distribution arrangement with Atari Inc recently and will exclusively distribute the game in North America. Empire Interactive (http://www.us.empireinteractive.com) has published interactive entertainment software for the last 19 years.

VIASPACE Subsidiary's $750,000 Army Contract for Robotic Detection of Chemical Warfare Agents and Explosives Featured in Defense News

subsidiary Ionfinity has been awarded a $750,000 Phase II contract for its proposal entitled "Advanced Robotic Detection of Chemical Agents, Toxic Industrial Gases, and Improvised Explosive Devices (IED)s for Force Health Protection" submitted to the Army Small Business Technology Transfer (STTR) Program. The contract was recently featured in Defense News in an article entitled:

Barr Subsidiary Faces Lawsuits, Disputes Prevacid Patents

A Barr Pharmaceuticals subsidiary is being sued after filing an ANDA to market generic 15- and 30-mg strengths of Tap Pharmaceutical’s heartburn drug Prevacid SoluTab.

VIASPACE Subsidiary's $750,000 Army Contract for Robotic Detection of Chemical Warfare Agents and Explosives Featured in Defense News

PRNewswire-FirstCall/ -- VIASPACE Inc. (OTC Bulletin Board: VSPC) subsidiary Ionfinity has been awarded a

VIASPACE Subsidiary Wins $750,000 Army Contract for Robotic Detection of Chemical Warfare Agents and Explosives

PRNewswire-FirstCall/ -- VIASPACE Inc. (OTC Bulletin Board: VSPC) subsidiary Ionfinity has been awarded a

VIASPACE Subsidiary Robotic Detection Proposal Competitively Selected by Army

(NewsRx.com) -- VIASPACE Inc. (BULLETIN BOARD: VSPC) subsidiary Ionfinity has been notified that its Phase II proposal entitled "Advanced Robotic Detection of Chemical Agents, Toxic Industrial Gases, and IEDs for Force Health Protection" submitted to the Army Small Business Technology Transfer (STTR) Program, has been competitively selected for negotiation and possible contract award. Phase II STTR projects are for two years and up to $750,000 in funding. Ionfinity expects to enter into contract negotiations with the Army shortly.

Merck subsidiary plans to launch patented drugs

CHENNAI: Merck Sharp & Dohme (MSD) Pharmaceuticals, the wholly-owned subsidiary of multinational giant Merck &Co Inc, is betting big on India, an emerging market for its patented and first research-based vaccines and products.

SurModics' Subsidiary Brookwood and PharmaSol Ink License Deal

SurModics, a provider of surface modification and drug delivery technologies to the healthcare industry, announced that its Brookwood Pharmaceuticals subsidiary has licensed lipid nanoparticle technology from PharmaSol of Berlin, Germany.

Capcom Adds French Subsidiary

The Japanese publisher has added a French subsidiary to its existing European operations in Germany and the UK...

Capcom to Establish French Subsidiary

Japanese publisher Capcom has revealed plans to establish a subsidiary in France to help drive European sales of its games.

Robotics Pioneer KUKA Roboter Founds Subsidiary in Moscow

KUKA Roboter, one of the world’s leading suppliers of industrial robots, is expanding its business into Russia.“KUKA Robotics RUS� is the name of the new subsidiary in Moscow. New markets, particularly in general industry, are opening up for the Augsburg-based company in the world’s largest country. The main impetus behind the founding of the new company in Russia was the desire expressed by international KUKA partners to have access to KUKA products and services here. For KUKA, customer proximity is an essential condition for successful collaboration in order to explore, together with the customer, what advantages and opportunities the use of robots could bring.

RAD Data Communications Names President of US Subsidiary

RAD Data Communications has named Uri Zilberman as president of its U.S. subsidiary. Zilberman has been instrumental in driving RAD’s U.S. sales for the past decade. He began his career at RAD’s international headquarters as a product manager in the mid-1990s and continued with a similar assignment at RAD Data Communications, Inc. In 2000, he became president of RADirect, RAD’s North American online sales branch.

Optimal Group: Divesting Optimal Payments Subsidiary, Growing WowWee

Optimal Group, Inc. (OPMR) expects to divest itself of its remaining U.S. Optimal Payment assets within the next 12 months. This means that the company will be focusing primarily on the growth of its WowWee subsidiary.

Innovium Investment Seed Media Group LLC Subsidiary ScienceBlogs Achieves Record Growth

Innovium Media Properties Corp. ("Innovium") (TSX VENTURE: IN)(FRANKFURT: IH7) reports that ScienceBlogs, LLC, the web's largest science community and a subsidiary of its primary investment Seed Media Group LLC ("Seed") provided an update. Traffic for the first six months of 2008 increased by more than 60% over the same period last year, with total visits through June 30th reaching approximately 14 million, an all-time high.

Innovium Investment Seed Media Group LLC Subsidiary ScienceBlogs Achieves Record Growth

TORONTO, ONTARIO--(Marketwire - July 3, 2008) - Innovium Media Properties Corp. ("Innovium") (TSX VENTURE:IN)(FRANKFURT:IH7) reports that ScienceBlogs, LLC, the web's largest science community and a subsidiary of its primary investment Seed Media Group LLC ("Seed") provided an update. Traffic for the first six months of 2008 increased by more than 60% over the same period last year, with total visits through June 30th reaching approximately 14 million, an all-time high.

Innovium Investment Seed Media Group LLC Subsidiary ScienceBlogs Achieves Record Growth

TORONTO, ONTARIO--(MARKET WIRE)--Jul 3, 2008 -- Innovium Media Properties Corp. ("Innovium") (CDNX:IN.V - News)(Frankfurt:IH7.F - News) reports that ScienceBlogs, LLC, the web's largest science community and a subsidiary of its primary investment Seed Media Group LLC ("Seed") provided an update. Traffic for the first six months of 2008 increased by more than 60% over the same period last year, with total visits through June 30th reaching approximately 14 million, an all-time high.

Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges

PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) announced today that its Barr Laboratories subsidiary has signed a Settlement Agreement and a License Agreement with Boehringer Ingelheim to resolve the patent litigation involving Boehringer Ingelheim's Mirapex(R) product. Separately, Barr Laboratories entered into a Settlement Agreement and a Supply Agreement to resolve the patent litigation regarding Boehringer Ingelheim's Aggrenox(R) product and Duramed Pharmaceuticals, a subsidiary of Barr Pharmaceuticals, entered into a Co-Promotion Agreement with Boehringer Ingelheim relating to Aggrenox(R).

Barr Announces Agreements to Settle Mirapex and Aggrenox Patent Challenges

MONTVALE, N.J., August 12, 2008 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. announced today that its Barr Laboratories subsidiary has signed a Settlement Agreement and a License Agreement with Boehringer Ingelheim to resolve the patent litigation involving Boehringer Ingelheim's Mirapex(R) product. Separately, Barr Laboratories entered into a Settlement Agreement and a Supply Agreement to resolve the patent litigation regarding Boehringer Ingelheim's Aggrenox(R) product and Duramed Pharmaceuticals, a subsidiary of Barr Pharmaceuticals, entered into a Co-Promotion Agreement with Boehringer Ingelheim relating to Aggrenox(R).

Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges

MONTVALE, N.J., Aug. 12 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) announced today that its Barr Laboratories subsidiary has signed a Settlement Agreement and a License Agreement with Boehringer Ingelheim to resolve the patent litigation involving Boehringer Ingelheim's Mirapex(R) product. Separately, Barr Laboratories entered into a Settlement Agreement and a Supply Agreement to resolve the patent litigation regarding Boehringer Ingelheim's Aggrenox(R) product and Duramed Pharmaceuticals, a subsidiary of Barr Pharmaceuticals, entered into a Co-Promotion Agreement with Boehringer Ingelheim relating to Aggrenox(R).

Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges

MONTVALE, N.J., Aug. 12 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL - News) announced today that its Barr Laboratories subsidiary has signed a Settlement Agreement and a License Agreement with Boehringer Ingelheim to resolve the patent litigation involving Boehringer Ingelheim's Mirapex® product. Separately, Barr Laboratories entered into a Settlement Agreement and a Supply Agreement to resolve the patent litigation regarding Boehringer Ingelheim's Aggrenox® product and Duramed Pharmaceuticals, a subsidiary of Barr Pharmaceuticals, entered into a Co-Promotion Agreement with Boehringer Ingelheim relating to Aggrenox®.

NTT Data acquires majority stake in Matsushita mobile phone unit

NTT Data, a division of Nippon Telegraph and Telephone (NTT) which builds computer networks and provides maintenance services, is acquiring a 60% stake in a mobile phone software subsidiary of Matsushita Electric Industrial, Japan's second largest handset manufacturer. Bloomberg reports that NTT Data is purchasing the stake from Matsushita's mobile phone arm Panasonic Mobile Communications, which currently owns 100% of the unit. The NTT subsidiary hopes the acquisition will triple its software sales to JPY30 billion (USD282 million) by 31 March 2011. No financial details of the deal were disclosed.

Applied Nanotech Holdings, Inc. Announces Court Decision

Applied Nanotech Holdings, Inc. (OTCBB: APNT) announced that the U.S. Court of Appeals for the Fifth Circuit issued its opinion in its litigation with Canon, Inc. The appeals court in part affirmed, and in part reversed, the rulings of the district court. While the appeals court accepted, without deciding, the district court's decision that SED, Inc. as originally formed did not qualify as a Canon subsidiary, and that Canon had materially breached the contract, it found that termination of the license agreement was not an appropriate remedy. The appeals court also ruled that the restructured SED, Inc., which is 100% owned by Canon, now qualifies as a Canon subsidiary. The appeals court denied Applied Nanotech's appeal that the district court had improperly excluded certain evidence from the trial.

Applied Nanotech Holdings, Inc. Announces Court Decision

Applied Nanotech Holdings, Inc. (OTCBB: APNT) announced that the U.S. Court of Appeals for the Fifth Circuit issued its opinion in its litigation with Canon, Inc. The appeals court in part affirmed, and in part reversed, the rulings of the district court. While the appeals court accepted, without deciding, the district court's decision that SED, Inc. as originally formed did not qualify as a Canon subsidiary, and that Canon had materially breached the contract, it found that termination of the license agreement was not an appropriate remedy. The appeals court also ruled that the restructured SED, Inc., which is 100% owned by Canon, now qualifies as a Canon subsidiary. The appeals court denied Applied Nanotech's appeal that the district court had improperly excluded certain evidence from the trial.

Search took 0.03 seconds.